Piedmont Investment Advisors’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-21,655
Closed -$1.88M 817
2017
Q2
$1.88M Buy
21,655
+6,543
+43% +$488K 0.04% 276
2017
Q1
$954K Buy
15,112
+8,251
+120% +$545K 0.02% 320
2016
Q4
$451K Hold
6,861
0.01% 334
2016
Q3
$476K Buy
6,861
+6,800
+11,148% +$459K 0.01% 317
2016
Q2
$3.83K Sell
61
-6
-9% -$371 ﹤0.01% 277
2016
Q1
$4.2K Hold
67
﹤0.01% 279
2015
Q4
$4.56K Sell
67
-5
-7% -$325 ﹤0.01% 280
2015
Q3
$4.46K Hold
72
﹤0.01% 285
2015
Q2
$4.63K Hold
72
﹤0.01% 285
2015
Q1
$4.97K Hold
72
﹤0.01% 195
2014
Q4
$4K Sell
72
-6
-8% -$346 ﹤0.01% 205
2014
Q3
$4.92K Sell
78
-50
-39% -$2.85K ﹤0.01% 200
2014
Q2
$6.76K Buy
128
+61
+91% +$3.06K ﹤0.01% 201
2014
Q1
$3.62K Sell
67
-10
-13% -$512 ﹤0.01% 235
2013
Q4
$3.48K Buy
77
+59
+328% +$2.7K ﹤0.01% 226
2013
Q3
$903 Hold
18
﹤0.01% 275
2013
Q2
$827 Buy
+18
New +$791 ﹤0.01% 300

Other funds holding PRXL

Piedmont Investment Advisors's PRXL Position: Q3 2017 in Review

Piedmont Investment Advisors sold out of Parexel International Corp (PRXL) in Q3 2017, closing a stake of 21,655 shares — an estimated $1.88M sold.

Piedmont Investment Advisors first reported a position in PRXL in Q2 2013 and held it in 17 quarters. The position peaked at $1.88M in Q2 2017. 246 funds tracked by Wall St. Rank hold PRXL as of Q3 2017.

  • Piedmont Investment Advisors reported no remaining Parexel International Corp position as of Q3 2017 after selling out during the quarter.
  • Piedmont Investment Advisors sold 21,655 Parexel International Corp shares in Q3 2017, an estimated $1.88M.
  • Piedmont Investment Advisors first reported a position in Parexel International Corp in Q2 2013 and held it in 17 quarters.
  • Piedmont Investment Advisors's Parexel International Corp position peaked at $1.88M in Q2 2017.
  • 246 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2017.

Based on Piedmont Investment Advisors's 13F filing for Q3 2017, filed 15 Nov 2017.